Receive Our Newsletter


Autologous cellular implants for dermal therapies

Proven Effective

Minimally Invasive

Easy and accessible

Undergoing clinical trial


Today, severe damage to the skin from burns and other wounds is often treated with reconstructive surgery. These treatments may include skin grafts, whereby skin is removed from one part of the body of the patient or a donor and transplanted to another, or tissue expansion, which slowly stretches the skin until enough has been grown to repair the site of damage. As with any surgical intervention, these treatments may introduce unnecessary risk, from loss of sensation to pain and infection.

Soon there will be a new, less invasive option: cellular medicine. This process with the SVF-2 uses the patientʼs own cells to create a healing environment within their body, enabling the bodyʼs innate healing intelligence to allow the skin to heal itself. Although it is still undergoing clinical trials, this process has shown promise for the treatment of a variety of conditions, including damage from wounds, burns, scars, radiation, peripheral vascular disease, and even diabetic foot ulcers.

The Process is Simple


Using the SVF-2, a small sample of adipose tissue is extracted from the patient.



Using the SVF-2, a small sample of adipose tissue is extracted from the patient.



From that tissue, we isolate a heterogenous mixture of the essential stromal and vascular cells that enable natural tissue repair and regeneration.



The autologous cellular implant is then extracted from the SVF-2 device and then reintroduced into the body at site of damage.

In more severe cases, surgical intervention may still be required, but for many, this procedure may present a long-term, non-surgical, regenerative solution.